Allergic conjunctivitis may be related to sleep disturbances in what may be a “self-perpetuating loop,” according to a poster ...

At this year’s American College of Allergy, Asthma & Immunology Scientific Meeting, Anne K. Ellis, MD, MSc, FACAAI, received ...

Global healthcare solutions company specialising in digital-first commercialization services for biopharma, emerging biotech and medical device companies, has partnered with Verified Market Research ...

Winter​‍​‌‍​‍‌​‍​‌‍​‍‌ eye irritations, unlike eye infections caused by the monsoons, escalate slowly and are, in most cases, ...

As of Tuesday, December 16, Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 28.04%, which has investors questioning if this is right time to sell.

Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026All ...

Air pollution is no longer just harming your lungs it is steadily affecting eye health across Indian cities. Doctors report a sharp rise in dryness, redness, irritation, and long-term ocular problems ...

Aldeyra Therapeutics announces PDUFA extension date by US FDA for NDA of Reproxalap to treat dry eye disease: Lexington, Massachusetts Thursday, December 18, 2025, 16:00 Hrs [IST] ...

Aldeyra Therapeutics ( ($ALDX) ) has provided an update. On December 15, 2025, Aldeyra Therapeutics announced that the FDA has extended the PDUFA ...

Detailed price information for Diagnostear Technologies Inc. (DTR-CN) from The Globe and Mail including charting and trades.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that ...

A leading eye specialist reveals shocking everyday habits that can damage your vision from home remedies to rubbing your eyes. Learn what to avoid for healthy eyesight.